Logical Evolution of Coverage: The Ontario Drug Benefit already covers semaglutide, and expanding coverage to include Mounjaro represents a logical step forward in modernizing treatment options within the ODB Program
Key Takeaways GGT is more than a liver enzyme It reflects oxidative stress, detox burden, and metabolic risk Elevations often occur before overt disease Alcohol, insulin resistance, and inflammation are major drivers Integrative strategies can meaningfully lower GGT The Bigger Picture Elevated GGT is not a diagnosis
Can Semaglutide Cause or Aggravate Gastritis
Phosphodiesterase-5 inhibitors (PDE5is) PDE5is is a first-line oral drug recommended by the World Health Organization (WHO) for the treatment of ED, and has also begun to be widely used for the treatment of diabetic ED, including sildenafil, tadalafil, Vardenafil, etc
Do you offer virtual visits
We use the New Direction High-protein medical-grade meal replacement shakes and soup as a crucial tool in these strategies
